FDA's Schwetz Is Acting Commissioner Following Henney Resignation
This article was originally published in The Tan Sheet
Executive Summary
FDA acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of Commissioner Jane Henney, MD.
You may also be interested in...
Von Eschenbach Resigning In January With BTC Debate In His Legacy
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed
Von Eschenbach Resigning In January With BTC Debate In His Legacy
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed
Von Eschenbach Resigning In January With BTC Debate In His Legacy
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed